Real-world treatment patterns and survival of BRAF V600-mutated metastatic non-small cell lung cancer patients.

被引：0
|
作者：
Horn, Leora
Bauml, Joshua
Forde, Patrick M.
Davis, Keith L.
Myall, Nathaniel James
Sasane, Medha
Dalal, Anand
Culver, Kenneth W.
Wozniak, Antoinette J.
Baik, Christina S.
Mutebi, Alex
Zhang, Pingkuan
Wakelee, Heather A.
Johnson, Bruce E.
机构：
[1] Vanderbilt Univ Sch Med, Nashville, TN USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Johns Hopkins Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[4] Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA
[5] RTI Hlth Solut, Durham, NC USA
[6] Stanford Hlth Care, Palo Alto, CA USA
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[9] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[10] Stanford Canc Inst, Stanford, CA USA
[11] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9096
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada
    Laforty, C.
    Tong, M.
    Sharma, A.
    Kim, Y.
    Devost, N.
    Qadeer, R.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S656 - S657
  • [22] REAL-WORLD PATTERNS OF BIOMARKER TESTING IN METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Roncadori, A.
    Massa, I
    Balzi, W.
    Danesi, V
    Rengucci, C.
    Gentili, N.
    Crino, L.
    Delmonte, A.
    Altini, M.
    VALUE IN HEALTH, 2022, 25 (01) : S255 - S255
  • [23] Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
    Apter, Lior
    Moser, Sarah Sharman
    Arunachalam, Ashwini
    Gazit, Sivan
    Hoshen, Moshe
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey
    Hollie Bailey
    Adam Lee
    Laura Eccles
    Yong Yuan
    Helen Burlison
    Cameron Forshaw
    Nebibe Varol
    BMC Cancer, 23
  • [25] Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey
    Bailey, Hollie
    Lee, Adam
    Eccles, Laura
    Yuan, Yong
    Burlison, Helen
    Forshaw, Cameron
    Varol, Nebibe
    BMC CANCER, 2023, 23 (01)
  • [26] REAL-WORLD TREATMENT PATTERNS AMONG ADULT PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE US
    Chen, Y.
    Carlson, A.
    VALUE IN HEALTH, 2024, 27 (06) : S387 - S388
  • [27] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Hozefa A. Divan
    Marisa A. Bittoni
    Ashok Krishna
    David P. Carbone
    BMC Cancer, 24
  • [28] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Divan, Hozefa A.
    Bittoni, Marisa A.
    Krishna, Ashok
    Carbone, David P.
    BMC CANCER, 2024, 24 (01)
  • [29] Dual inhibition of BRAF and MEK in BRAF-mutated metastatic non-small cell lung cancer
    Kim, Young Hak
    JOURNAL OF THORACIC DISEASE, 2016, 8 (09) : 2369 - 2371
  • [30] Real-world experience in treatment of patients with non-small cell lung cancer with BRAF and cMET Exon 14 skipping mutations
    Janzic, U.
    Shalata, W.
    Agbarya, A.
    Dziadziuszko, R.
    Szymczak, K.
    Jakopovic, M.
    Mountzios, G.
    Pluzanski, A.
    ANNALS OF ONCOLOGY, 2023, 34
12345